☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
InnoCare
InnoCare Reports First Patient Dosing with ICP-189 in the P-Ib Trial for Treating Non-Small Cell Lung Cancer
March 29, 2024
PharmaShots Weekly Snapshots (March 11 – March 15, 2024)
March 15, 2024
InnoCare Receives IND Approval from NMPA to Initiate P-I Study of ICP-189 + Furmonertinib in NSCLC Patients
September 14, 2023
InnoCare Entered into a Clinical Development Collaboration with ArriVent to Evaluate ICP-189 + Furmonertinib for Advanced Non-Smal...
July 14, 2023
InnoCare Reports the First Patient Dosing of ICP-488 in Clinical Trial for the Treatment of Psoriasis in China
July 5, 2023
InnoCare’s Orelabrutinib Receives the NMPA’s Approval for the Treatment of Relapsed/Refractory Marginal Zone Lymphoma
April 20, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.